期刊文献+

氯氮平对超敏C反应蛋白及糖脂代谢的影响 被引量:1

Effect of clozapine on high-sensitivity C-reactive protein and metabolism of glucose and lipid
下载PDF
导出
摘要 目的:探讨氯氮平对精神分裂症患者超敏C反应蛋白(hs-CRP)以及糖、脂代谢的影响。方法:对30例服用氯氮平治疗的精神分裂症患者(患者组)作hs-CRP、空腹血糖、三酰甘油、胆固醇、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、载脂蛋白A1(ApoA1)、载脂蛋白B(ApoB)检测,于治疗前、治疗第4、8、12周各检测1次。并与30名健康者(对照组)进行比较。结果:治疗前患者组和对照组糖脂各值差异无显著性。在治疗第4、8、12周的hs-CRP,第12周的空腹血糖、三酰甘油、胆固醇、LDL、ApoB比治疗前明显升高;治疗第12周的HDL、ApoA1比治疗前明显下降;hs-CRP与空腹血糖、三酰甘油、胆固醇以及氯氮平剂量呈正相关。结论:氯氮平对hs-CRP、糖脂代谢均会产生影响,氯氮平导致代谢综合征可能与hs-CRP有关。 Objective:To explore, the effect of elozapine on high-sensitivity C-reactive protein (hs-CRP) and metabolism of glucose and lipids in patients with schizophrenia. Method: Hs-CRP, fasting plasma glucose, triglye-eride, cholesterol, high density lipoprotein cholesterol (HDL), low density lipoprotein cholesterol (LDL), apoprotein A1 (ApoA1) and apoprotein B (ApoB) were measured in thirty patients with schizophrenia treated with clozapine (patient group) before and after treatment 4,8,12 weeks and in thirty healthy controls (control group). Results:There were no significant difference between the two groups for all indices above before treatment. For patients with schizophrenia,hs-CRP at 4,8 and 12 weeks increased obviously compared with that before treatment. Fasting plasma glucose, triglyeeride, cholesterol, LDL, apoB at 12 weeks increased significandy, and HDL and ApoA1 at 12 weeks lowed significantly than those at baseline. The level of hs-CRP was positively correlated with fasting plasma glucose, triglyceride, cholesterol and dosage of clozapine. Condusion: Clozapine has effects on hs-CRP and metabolism of glucose and lipid. Metabolism syndrome induced by clozapine may relate to hs-CRP.
机构地区 天津市安定医院
出处 《临床精神医学杂志》 2008年第1期9-11,共3页 Journal of Clinical Psychiatry
关键词 精神分裂症 氯氮平 C反应蛋白 血糖 血脂 schizophrenia clozapine C-reactive protein blood glucose blood lipid
  • 相关文献

参考文献7

二级参考文献39

  • 1司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95
  • 2张苏明,梅爱农.代谢综合征、胰岛素抵抗与脑血管疾病[J].中华神经科杂志,2004,37(5):468-470. 被引量:30
  • 3张向阳,国外医学精神病学分册,1995年,22卷,74页
  • 4范少光,神经科学纲要,1993年
  • 5王小宁,上海免疫学杂志,1991年,11卷,38页
  • 6郭泉涌,中华神经精神科杂志,1986年,19卷,185页
  • 7Naudin J, Capo C, Giusano B, et al. A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr Res,1997, 26:227-233.
  • 8Ganguli R, Yang Z, Shurin G, et al. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res, 1994, 51:1-10.
  • 9Maes M, Bosmans E, Calabrese J, et al. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res, 1995, 29:141-152.
  • 10Muller N, Empl M, Riedel M, et al. Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia. Eur Arch Psychiatry Clin Neurosci, 1997, 247:308-313.

共引文献140

同被引文献4

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部